EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2)

Jens Pietzsch iD, Magali Toussaint iD, Cornelius Kurt Donat, Alina Doctor, Sebastian Meister, Johanna Wodtke, Markus Laube iD, Frank Hofheinz, Jan Rix iD, Winnie Deuther-Conrad iD, Cathleen Haase-Kohn iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jens Pietzsch und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR)…. Hauptthemen laut MEDLINE: Cyclooxygenase 2, Macrophages, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, LiSyM Cancer phase I joint collaborative project DEEP-HCC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive form of malignant gliomas, with the eicosanoid-synthesizing enzyme cyclooxygenase-2 (COX-2) playing a pivotal role in its progression via the COX-2/prostaglandin E2/4 axis. COX-2 upregulations in tumor cells induces a pro-inflammatory tumor microenvironment (TME), affecting the behavior of invading bone marrow-derived macrophages (Mϕ) and brain-resident microglia (MG) through unclear autocrine and paracrine mechanisms. Using CRISPR/Cas9 technology, we generated COX-2 knockout U87 glioblastoma cells. In spheroids and in vivo xenografts, this resulted in a significant inhibition of tumorigenic properties, while not observed in standard adherent monolayer culture. Here, the knockout induced a G1 cell cycle arrest in adherent cells, accompanied by increased ROS, mitochondrial activity, and cytochrome c-mediated apoptosis. In spheroids and xenograft models, COX-2 knockout led to notable growth delays and increased cell death, characterized by features of both apoptosis and autophagy. Interestingly, these effects were partially reversed in subcutaneous xenografts after co-culture with Mϕ, while co-culture with MG enhanced the growth-suppressive effects. In an orthotopic model, COX-2 knockout tumors displayed reduced proliferation (fewer Ki-67 positive cells), increased numbers of GFAP-positive astrocytes, and signs of membrane blebbing. These findings highlight the potential of COX-2 knockout and suppression as a therapeutic strategy in GBM, particularly when combined with suppression of infiltrating macrophages and stabilization of resident microglia populations to enhance anti-tumor effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclooxygenase 2MacrophagesGliomaBrain NeoplasmsGlioblastomaAnimalsHumansMiceCell Line, TumorTumor MicroenvironmentDisease ProgressionApoptosisCell ProliferationXenograft Model Antitumor Assays

Stichwörter der Autor:innen

CRISPR/Cas9bone marrowprostaglandinssessile macrophagesspheroid modeltumor microenvironmenttumor xenografts

Substanzen

Cyclooxygenase 2PTGS2 protein, human

Autor:innen und Institutionen

  • Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328 Dresden, Germany.
  • School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, 01062 Dresden, Germany.
  • Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 04318 Leipzig, Germany.
  • Department of Medicinal Radiochemistry, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
  • Department of Positron Emission Tomography, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
  • Department of Medical Physics and Biomedical Engineering, Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany.

ORCID-Profile: Jens Pietzsch, Magali Toussaint, Markus Laube, Jan Rix, Winnie Deuther-Conrad, Cathleen Haase-Kohn

Förderung

  • Deutsche Forschungsgemeinschaft
  • LiSyM Cancer phase I joint collaborative project DEEP-HCC

Zitieren

APA

Pietzsch, J., Toussaint, M., Donat, C. K., Doctor, A., Meister, S., Wodtke, J., Laube, M., Hofheinz, F., Rix, J., Deuther-Conrad, W., & Haase-Kohn, C. (2025). Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136198

Vancouver

Pietzsch J, Toussaint M, Donat CK, Doctor A, Meister S, Wodtke J, et al. Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2). International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136198

BibTeX
@article{Pietzsch2025,
  author = {Pietzsch, Jens and Toussaint, Magali and Donat, Cornelius Kurt and Doctor, Alina and Meister, Sebastian and Wodtke, Johanna and Laube, Markus and Hofheinz, Frank and Rix, Jan and Deuther-Conrad, Winnie and Haase-Kohn, Cathleen},
  title = {Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2)},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136198}
}
Kostenlos starten →